The Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards) is pleased to announce that AstraZeneca has joined as a funding partner. AstraZeneca will support five medical students in the 2026 Winn Clinical Investigator Pathway Program (Winn CIPP), a six-week immersive summer program that prepares future physicians and clinical researchers to expand access to clinical trials and engage medically underrepresented communities. This partnership strengthens the Winn Awards’ mission of Better Science For All by providing opportunities for medical students from all backgrounds to explore community-engaged clinical research opportunities.

An international team of scientists is warning that everyday antibacterial soaps, wipes, sprays, and other “germ‑killing” products are quietly contributing to the global rise of antimicrobial resistance (AMR) while providing no added health benefit for most consumer uses. 

In a multicenter retrospective Chinese ICU cohort (5 hospitals, 2012–2023; 9,221 pediatric suspected-infection admissions; 13.4% mortality), the Phoenix Sepsis Score showed only moderate discrimination for in-hospital death (AUROC 0.60). Using XGBoost/SHAP-guided, clinically feasible predictors, the authors created PSS+, presented as a logistic regression nomogram, improving discrimination in internal (AUROC 0.75) and external (AUROC 0.71) validation versus PSS-4/8 and pSOFA.

Nanofilm electrodes capable of detecting stress in plants through bioelectric potentials could pave the way for more resilient agriculture, report researchers from Institute of Science Tokyo. Thanks to the electrode’s small thickness, leaf surface hairs can easily pierce through it, enabling stable and long-term electrical contact without compromising the leaf’s natural processes. This work could help improve crop yields by enabling early detection of stress in plants.

Microbial metabolites influence health far beyond the intestinal tract. Yet, a systematic understanding of how these molecules precisely control specific immune cell functions and regulate disease has remained elusive. A comprehensive review by the team of Professor Changtao Jiang and Dr. Kai Wang at Peking University addresses this gap. The article provides a critical theoretical foundation for understanding the gut microbiota-metabolite-immune axis in disease pathogenesis and for developing targeted intervention strategies.